U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane®) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancer
Saif, M.Wasif.
Jop Journal of the Pancreas 14(6): 686-688
2013
ISSN/ISBN: 1590-8577 PMID: 24216565 Document Number: 669194
Document emailed within 1 workday
Related Documents
Baltali, Eşmen.; Altundağ, M.Kadri.; Güler, Nüfer.; Ozişik, Y.; Firat, Dçer.; Baran, I.; Tekuzman, Gülten. 2002: Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer Tumori 88(3): 200-203Delfino, C.; Caccia, G.; Riva Gonzáles, L.; Mickiewicz, E.; Rodger, J.; Balbiani, L.; Flores Morales, D.; Zori Comba, A.; Brosio, C. 2003: Gemcitabine/paclitaxel as first-line treatment of advanced breast cancer Oncology 17(12 Suppl 14: 22-25
Kawamura, M.; Nakano, S.; Kyoda, S.; Tabei, I.; Yoshida, K.; Takeyama, H. 2013: Administration of low-dose albumin-bound paclitaxel for the treatment of advanced and recurrent breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 909-912
Lück, H.J.; Thomssen, C.; du Bois, A.; Lisboa, B.W.; Untch, M.; Kühnle, H.; Jänicke, F.; Meerpohl, H.G.; Lindner, C.; Konecny, G.; Hecker, D.; Diergarten, K. 1997: Preliminary results of a phase Ii study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer Seminars in Oncology 24(1 Suppl 3: S13-S16
Fountzilas, G.; Athanassiades, A.; Kalogera-Fountzila, A.; Samantas, E.; Bacoyiannis, C.; Briassoulis, E.; Pavlidis, N.; Kosmidis, P.; Skarlos, D. 1997: Paclitaxel in combination with carboplatin or gemcitabine for the treatment of advanced head and neck cancer Seminars in Oncology 24(6 Suppl 19: S19
Holmes, F.A. 1996: Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review Seminars in Oncology 23(5 Suppl 11: 46-56
Takahata, T.; Sato, A.; Yu, C.; Saito, K. 2018: Retrospective Analysis of Weekly Paclitaxel Chemotherapy for Gemcitabine- and S-1-Resistant Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 817-821
Baker, R. 1995: FDA approves baboon bone marrow transplant for AIDS patient. Food and Drug Administration Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 1995: 7-8
Klaassen, U.; Harstrick, A.; Wilke, H.; Seeber, S. 1996: Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer Seminars in Oncology 23(1 Suppl 1: 44-47
Yagi, Y.; Ichikawa, K.; Takahashi, K.; Okuda, N. 2007: A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 261-263
Nakamoto, S.; Nishiyama, R.; Kaneda, T.; Yokota, M.; Kawamata, H.; Tajima, H.; Kaizu, T.; Kumamoto, Y.; Yamauchi, H.; Okuwaki, K.; Iwai, T.; Imaizumi, H.; Suzuki, E.; Hara, A.; Ichinoe, M.; Kida, M.; Watanabe, M. 2017: Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(2): 173-176
Inal, A.; Kos, F.T.; Algin, E.; Yildiz, R.; Berk, V.; Tugba Unek, I.; Colak, D.; Colak, D.; Kucukoner, M.; Tamer Elkiran, E.; Helvaci, K.; Geredeli, C.; Dane, F.; Balakan, O.; Ali Kaplan, M.; Gok Durnali, A.; Harputoglu, H.; Goksel, G.; Ozdemir, N.; Buyukberber, S.; Gumus, M.; Ozkan, M.; Benekli, M.; Isikdogan, A. 2012: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study Journal of BUON: Official Journal of the Balkan Union of Oncology 17(1): 102-105
Senderowicz, A.M.; Johnson, J.R.; Sridhara, R.; Zimmerman, P.; Justice, R.; Pazdur, R. 2007: Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas Oncology 21(14): 1696-1706; Discussion: 1706-1709 1712, 1715
Xing, P.Y.; Hao, X.Z.; Wang, Y.; Hu, X.S.; Li, J.L. 2016: Retrospective analysis of albumin-bound paclitaxel in the treatment of elderly patients with advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 38(8): 615-619
Watanabe, F.; Honda, G.; Kurata, M.; Tsuruta, K.; Tokashiki, T.; Funada, N. 2009: A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2430-2432
Makari, Y.; Fujiwara, Y.; Yasuda, T.; Takiguchi, S.; Kimura, Y.; Yano, M.; Monden, M. 2004: Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(4): 609-611
Kietpeerakool, C.; Tiyayon, J.; Suprasert, P.; Kanjanavanit, R.; Srisomboon, J. 2006: Benefit of electrocardiography during front-line combination paclitaxel and carboplatin chemotherapy for epithelial ovarian cancer Journal of the Medical Association of Thailand 89(11): 1805-1810
Kimura, M.; Koida, T.; Yanagita, Y. 2000: Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(11): 1703-1708
Tanaka, S.; Fujii, M.; Goubaru, M.; Ohta, T.; Ogata, M.; Makino, Y. 2005: Locally advanced pancreatic cancer that enlarged after administration of gemcitabine and responded to oral TS-1--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(10): 1485-1487
Fujimoto, C.; Maruyama, Y.; Niina, Y.; Fujimori, N.; Sumii, T.; Funakoshi, A. 2008: A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(6): 1013-1016